Literature DB >> 31440931

Impact of Age on Locoregional and Distant Recurrence After Mastectomy for Ductal Carcinoma In Situ With or Without Microinvasion.

Anita Mamtani1, Faina Nakhlis2, Stephanie Downs-Canner1, Emily C Zabor3, Monica Morrow1, Tari A King2, Kimberly J Van Zee4.   

Abstract

BACKGROUND: Locoregional recurrence (LRR) after breast-conserving surgery (BCS) for ductal carcinoma in situ (DCIS) is increased in young women. We examined the impact of age on LRR and distant disease after mastectomy for DCIS ± microinvasion.
METHODS: We identified consecutive patients with DCIS ± microinvasion treated with mastectomy from 1995 to 2017. LRR was defined as recurrence at the ipsilateral chest wall or regional nodes.
RESULTS: Overall, 3121 cases were identified, of which 421 (13.5%) had DCIS + microinvasion. Median age was 49 years and median follow-up was 6.4 years; 821 were followed for 10 or more years. Thirty-four LRRs were observed: 33 (97%) were invasive, and 23 (68%) were in the chest wall alone. Cumulative 10-year LRR incidence was 1.4%. Age < 50 years, high grade, and DCIS + microinvasion were associated with LRR (p ≤ 0.001); however, margin status was not (p = 0.14). Adjusting for grade and DCIS + microinvasion, age < 50 years (hazard ratio [HR] 14.7, 95% confidence interval [CI] 3.5-61.5; p < 0.001) was associated with LRR. Compared with women ≥ 50 years of age, women age < 40 years had the highest risk (HR 27.0, 95% CI 6.0-121), and women age 40-49 years had intermediate risk (HR 11.8, 95% CI 2.8-50.5). The cumulative 10-year LRR incidence was 4.2% for women < 40 years of age, 2.0% for women 40-49 years of age, and 0.2% for women ≥ 50 years of age. Women age < 40 years had a 10-year distant disease rate of 1.6% versus women age 40-49 years (0.7%) and women age ≥ 50 years (0.7%) (log-rank p = 0.051). Grade, DCIS + microinvasion, and margins were unassociated with distant disease.
CONCLUSIONS: LRR after mastectomy for DCIS ± microinvasion is uncommon, but is more frequent among women < 50 years of age, particularly in those < 40 years of age. The 10-year LRR rate in this youngest group remains low at 4.2%. Young age is an independent risk factor for LRR after BCS or mastectomy.

Entities:  

Mesh:

Year:  2019        PMID: 31440931      PMCID: PMC6868329          DOI: 10.1245/s10434-019-07693-1

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  23 in total

1.  Effect of radiotherapy after breast-conserving surgery for ductal carcinoma in situ: 20 years follow-up in the randomized SweDCIS Trial.

Authors:  Fredrik Wärnberg; Hans Garmo; Stefan Emdin; Veronica Hedberg; Linda Adwall; Kerstin Sandelin; Anita Ringberg; Per Karlsson; Lars-Gunnar Arnesson; Harald Anderson; Karin Jirström; Lars Holmberg
Journal:  J Clin Oncol       Date:  2014-10-13       Impact factor: 44.544

2.  Trends in Treatment Patterns and Clinical Outcomes in Young Women Diagnosed With Ductal Carcinoma In Situ.

Authors:  Hannah Lui Park; Jenny Chang; Gagandeep Lal; Krustina Lal; Argyrios Ziogas; Hoda Anton-Culver
Journal:  Clin Breast Cancer       Date:  2017-08-10       Impact factor: 3.225

3.  Predictors of microinvasion and its prognostic role in ductal carcinoma in situ.

Authors:  Gloria R Sue; Donald R Lannin; Brigid Killelea; Anees B Chagpar
Journal:  Am J Surg       Date:  2013-06-19       Impact factor: 2.565

4.  Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.

Authors:  Irene L Wapnir; James J Dignam; Bernard Fisher; Eleftherios P Mamounas; Stewart J Anderson; Thomas B Julian; Stephanie R Land; Richard G Margolese; Sandra M Swain; Joseph P Costantino; Norman Wolmark
Journal:  J Natl Cancer Inst       Date:  2011-03-11       Impact factor: 13.506

5.  Impact of Age on Risk of Recurrence of Ductal Carcinoma In Situ: Outcomes of 2996 Women Treated with Breast-Conserving Surgery Over 30 Years.

Authors:  Patricia A Cronin; Cristina Olcese; Sujata Patil; Monica Morrow; Kimberly J Van Zee
Journal:  Ann Surg Oncol       Date:  2016-05-19       Impact factor: 5.344

6.  Impact of microinvasion on breast cancer mortality in women with ductal carcinoma in situ.

Authors:  Victoria Sopik; Ping Sun; Steven A Narod
Journal:  Breast Cancer Res Treat       Date:  2017-11-08       Impact factor: 4.872

7.  Local recurrence of ductal carcinoma in situ after skin-sparing mastectomy.

Authors:  Grant W Carlson; Andrew Page; Earl Johnson; Kimberly Nicholson; Toncred M Styblo; William C Wood
Journal:  J Am Coll Surg       Date:  2007-05       Impact factor: 6.113

8.  Outcomes in patients treated with mastectomy for ductal carcinoma in situ.

Authors:  Dawn Owen; Scott Tyldesley; Cheryl Alexander; Caroline Speers; Pauline Truong; Alan Nichol; Elaine S Wai
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-11-27       Impact factor: 7.038

9.  Incidence and consequence of close margins in patients with ductal carcinoma-in situ treated with mastectomy: is further therapy warranted?

Authors:  Elizabeth Fitzsullivan; Sara A Lari; Benjamin Smith; Abigail S Caudle; Savitri Krishnamurthy; Anthony Lucci; Elizabeth A Mittendorf; Gildy V Babiera; Dalliah M Black; Jamie L Wagner; Isabelle Bedrosian; Wendy Woodward; Sarah M Gainer; Rosa Hwang; Funda Meric-Bernstam; Kelly K Hunt; Henry M Kuerer
Journal:  Ann Surg Oncol       Date:  2013-08-23       Impact factor: 5.344

Review 10.  Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast.

Authors:  C Correa; P McGale; C Taylor; Y Wang; M Clarke; C Davies; R Peto; N Bijker; L Solin; S Darby
Journal:  J Natl Cancer Inst Monogr       Date:  2010
View more
  7 in total

1.  Clinicopathologic Features, Treatment Patterns, and Disease Outcomes in a Modern, Prospective Cohort of Young Women Diagnosed with Ductal Carcinoma In Situ.

Authors:  Megan E Tesch; Shoshana M Rosenberg; Laura C Collins; Julia S Wong; Laura Dominici; Kathryn J Ruddy; Rulla Tamimi; Lidia Schapira; Virginia F Borges; Ellen Warner; Steven E Come; Ann H Partridge
Journal:  Ann Surg Oncol       Date:  2022-08-12       Impact factor: 4.339

2.  ASO Author Reflections: Advising a Woman with Ductal Carcinoma In Situ Regarding Various Treatment Options-A Complex Decision.

Authors:  Anita Mamtani; Kimberly J Van Zee
Journal:  Ann Surg Oncol       Date:  2019-09-23       Impact factor: 5.344

3.  Treatment of Ductal Carcinoma in Situ: Considerations for Tailoring Therapy in the Contemporary Era.

Authors:  Anita Mamtani; Kimberly J Van Zee
Journal:  Curr Breast Cancer Rep       Date:  2020-02-24

4.  Prognostic Factors and a Nomogram Predicting Survival in Patients with Breast Ductal Carcinoma in situ with Microinvasion: A Population-Based Study.

Authors:  Yi-Zi Zheng; Hong-Bin Qin; Zi-Zheng Li; He-Sheng Jiang; Greg Zhang; Shi-Wei Yang; Xian-Ming Wang; Yang-Chun Xu; Zhen-Han Deng; Guo-Wen Liu
Journal:  Clin Epidemiol       Date:  2021-11-30       Impact factor: 4.790

5.  Importance of long-term monitoring of patients with breast reconstructions: a case of 10-year cancer recurrence.

Authors:  Sarah Hardwick; Sanjeev Hariparsad; Nakul Kain; Charles M Malata
Journal:  Case Reports Plast Surg Hand Surg       Date:  2021-12-13

6.  Characteristics, prognosis, risk factors, and management of recently diagnosed ductal carcinoma in situ with microinvasion.

Authors:  Chunyan Li; Yilan Yang; Jiangfeng Wang; Kairui Jin; Zhaozhi Yang; Xiaoli Yu; Xiaomao Guo; Xingxing Chen
Journal:  Cancer Med       Date:  2021-09-21       Impact factor: 4.452

7.  Type of Recurrence, Cause of Death and Second Neoplasms among 737 Patients with Ductal Carcinoma In Situ of the Breast-15-Year Follow-Up.

Authors:  Anna Niwińska; Michał Kunkiel
Journal:  Cancers (Basel)       Date:  2022-01-28       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.